Cynthia Clayton

Health Technology

Consumer Services

Profile

Ms. Cynthia Clayton is VP-Investor Relations & Corporate Communications at Alnylam Pharmaceuticals, Inc. Ms. Clayton was previously employed as a Manager-Investor & Corporate Communications by Synta Pharmaceuticals Corp., a Principal by Curis, Inc., and Senior Manager-Investor & Corporate Communications by Millennium Pharmaceuticals, Inc. She received her undergraduate degree from the University of Hartford.

Former positions of Cynthia Clayton

Companies	Position	End
CURIS, INC.	Corporate Officer/Principal	-
Synta Pharmaceuticals Corp. Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Synta Pharmaceuticals Corp. discovers, develops and commercializes pharmaceutical products. It focuses on the research, development and commercialization of oncology medicines that provides treatment to cancer patients. The company is also developing a proprietary platform for delivery of anti-cancer drugs directly to tumor cells, known as Hsp90-inhibitor drug conjugates. Synta Pharmaceuticals was founded by Safi R. Bahcall and Lan-Bo Chen in March 2000 and is headquartered in Lexington, MA.	Public Communications Contact	-
Millennium Pharmaceuticals, Inc. Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA.	Public Communications Contact	-
ALNYLAM PHARMACEUTICALS, INC.	Investor Relations Contact	-

See the detail of Cynthia Clayton's experience

Training of Cynthia Clayton

University of Hartford

Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies